| Primary information |
|---|
| sequence ID | Seq_1528 |
| Peptide sequence | DSGEGDFLAEGGGVRGPR |
| CancerPDF_ID | CancerPDF_ID635, CancerPDF_ID2348, CancerPDF_ID8775, |
| PMID | 19795908,21136997,24694173 |
| Protein Name | Fibrinogen alpha chain,Fibrinogen alpha,Isoform 1 of Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Plasma,Plasma,Ascites fluid |
| M/Z | 592.61,1774.8234,NA |
| Charge | 3,1,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LTQ-Orbitrap XL |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,X tandem for peptide identification |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,NA,NA |
| CancerPDF_ID | CancerPDF_ID635, CancerPDF_ID2348, CancerPDF_ID8775, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),"X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 18,18,18 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Normal,Ovarian cancer |
| Database | NCBI refseq Protein Database,SwissProt Database,"IPI00021885,IPI00029717" |
| Modification | NA,NA,NA |
| Number of Patients | "42 normal, 28patients",27 healthy individuals,3 ovarian cancer patient and 3 non cancerous control |
| Regulation | NA,NA,Uniquely expressed in ovarian cancer patient |
| Validation | NA,Leave One out Cross validation,NA |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |